The rising cost of vitamin D testing in Australia: time to establish guidelines for testing

Kellie L Bilinski and Steven C Boyages
Med J Aust 2012; 197 (2): . || doi: 10.5694/mja12.10561
Published online: 16 July 2012

To the Editor: A rising awareness of the prevalence of 25-hydroxyvitamin D (25OHD) deficiency over the past decade is likely to have led to a surge in the number of individuals who undergo 25OHD testing.1 United States data indicate that testing for 25OHD has increased by 80%–90% annually,2 yet there are no reports that investigate the cost of 25OHD testing in Australia. We analysed the Medicare Benefits Schedule (MBS) to determine the economic impact of vitamin D testing in Australia from 1 January 2000 to 31 December 2010.

  • Kellie L Bilinski1
  • Steven C Boyages2

  • 1 Westmead Breast Cancer Institute, Sydney, NSW.
  • 2 eHealth NSW Initiative, Sydney, NSW.


Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.